Balance Sheet Data

FibroGen, Inc. (FGEN)

$0.6154

+0.04 (+6.10%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 621.40533.76686.54405.19422.01366.35350.30334.94320.26306.22
Total Cash (%)
Account Receivables 63.6828.4641.8817.4016.3022.5321.5520.6019.7018.83
Account Receivables (%)
Inventories -6.8916.5331.0140.4418.1617.3616.6015.8715.18
Inventories (%)
Accounts Payable 9.146.0924.7926.1030.7614.4413.8113.2112.6312.07
Accounts Payable (%)
Capital Expenditure -8.02-5.76-3.99-30.19-38.74-13.09-12.51-11.97-11.44-10.94
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.